Hyer ML - Search Results

1

Downregulation of c-FLIP sensitizes DU145 prostate cancer cells to Fas-mediated apoptosis.

Hyer ML, Sudarshan S, Kim Y, Reed JC, Dong JY, Schwartz DA, Norris JS. Hyer ML, et al. Cancer Biol Ther. 2002 Jul-Aug;1(4):401-6. doi: 10.4161/cbt.1.4.15. Cancer Biol Ther. 2002. PMID: 12432255

2

Quantification and characterization of the bystander effect in prostate cancer cells following adenovirus-mediated FasL expression.

Hyer ML, Sudarshan S, Schwartz DA, Hannun Y, Dong JY, Norris JS. Hyer ML, et al. Cancer Gene Ther. 2003 Apr;10(4):330-9. doi: 10.1038/sj.cgt.7700576. Cancer Gene Ther. 2003. PMID: 12679806

3

In vitro efficacy of Fas ligand gene therapy for the treatment of bladder cancer.

Sudarshan S, Holman DH, Hyer ML, Voelkel-Johnson C, Dong JY, Norris JS. Sudarshan S, et al. Among authors: hyer ml. Cancer Gene Ther. 2005 Jan;12(1):12-8. doi: 10.1038/sj.cgt.7700746. Cancer Gene Ther. 2005. PMID: 15514684

4

Intracellular Fas ligand expression causes Fas-mediated apoptosis in human prostate cancer cells resistant to monoclonal antibody-induced apoptosis.

Hyer ML, Voelkel-Johnson C, Rubinchik S, Dong J, Norris JS. Hyer ML, et al. Mol Ther. 2000 Oct;2(4):348-58. doi: 10.1006/mthe.2000.0139. Mol Ther. 2000. PMID: 11020350 Free article.

5

The use of Fas Ligand, TRAIL and Bax in gene therapy of prostate cancer.

Norris JS, Hyer ML, Voelkel-Johnson C, Lowe SL, Rubinchik S, Dong JY. Norris JS, et al. Among authors: hyer ml. Curr Gene Ther. 2001 May;1(1):123-36. doi: 10.2174/1566523013348977. Curr Gene Ther. 2001. PMID: 12109135 Review.

6

CD95 rapidly clusters in cells of diverse origins.

Fanzo JC, Lynch MP, Phee H, Hyer M, Cremesti A, Grassme H, Norris JS, Coggeshall KM, Rueda BR, Pernis AB, Kolesnick R, Gulbins E. Fanzo JC, et al. Cancer Biol Ther. 2003 Jul-Aug;2(4):392-5. doi: 10.4161/cbt.2.4.442. Cancer Biol Ther. 2003. PMID: 14508111

7

Combined therapeutic use of AdGFPFasL and small molecule inhibitors of ceramide metabolism in prostate and head and neck cancers: a status report.

Norris JS, Bielawska A, Day T, El-Zawahri A, ElOjeimy S, Hannun Y, Holman D, Hyer M, Landon C, Lowe S, Dong JY, McKillop J, Norris K, Obeid L, Rubinchik S, Tavassoli M, Tomlinson S, Voelkel-Johnson C, Liu X. Norris JS, et al. Cancer Gene Ther. 2006 Dec;13(12):1045-51. doi: 10.1038/sj.cgt.7700965. Epub 2006 Jun 9. Cancer Gene Ther. 2006. PMID: 16763610 Review.

8

The FLIP-side of Fas signaling.

Hyer ML, Samuel T, Reed JC. Hyer ML, et al. Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):5929-31. doi: 10.1158/1078-0432.CCR-06-2098. Epub 2006 Oct 6. Clin Cancer Res. 2006. PMID: 17028246 Review. No abstract available.

9

Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells.

Hyer ML, Croxton R, Krajewska M, Krajewski S, Kress CL, Lu M, Suh N, Sporn MB, Cryns VL, Zapata JM, Reed JC. Hyer ML, et al. Cancer Res. 2005 Jun 1;65(11):4799-808. doi: 10.1158/0008-5472.CAN-04-3319. Cancer Res. 2005. PMID: 15930300 Free article.

10

Apoptotic activity and mechanism of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic-acid and related synthetic triterpenoids in prostate cancer.

Hyer ML, Shi R, Krajewska M, Meyer C, Lebedeva IV, Fisher PB, Reed JC. Hyer ML, et al. Cancer Res. 2008 Apr 15;68(8):2927-33. doi: 10.1158/0008-5472.CAN-07-5759. Cancer Res. 2008. PMID: 18413762

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page